Steven E. Arnold, MD

Affiliations: 
Center for Neurobiology and Behavior University of Pennsylvania, Philadelphia, PA, United States 
Area:
Cellular and molecular neurobiology of schizophrenia and mood disorders, aging and neurodegenerative dementias
Website:
http://www.med.upenn.edu/ins/faculty/arnold.htm
Google:
"Steven Arnold"
Mean distance: 18.32 (cluster 19)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gangishetti U, Christina Howell J, Perrin RJ, et al. (2018) Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Alzheimer's Research & Therapy. 10: 98
Robinson JL, Lee EB, Xie SX, et al. (2018) Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain : a Journal of Neurology
Trombetta BA, Carlyle BC, Koenig AM, et al. (2018) The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease. Plos One. 13: e0193707
Jansen WJ, Ossenkoppele R, Tijms BM, et al. (2017) Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. Jama Psychiatry
Koenig AM, Mechanic-Hamilton D, Xie SX, et al. (2017) Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study. Alzheimer Disease and Associated Disorders. 31: 107-113
Roalf DR, Moore TM, Mechanic-Hamilton D, et al. (2017) Bridging cognitive screening tests in neurologic disorders: A crosswalk between the short Montreal Cognitive Assessment and Mini-Mental State Examination. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Quarmley M, Moberg PJ, Mechanic-Hamilton D, et al. (2016) Odor Identification Screening Improves Diagnostic Classification in Incipient Alzheimer's Disease. Journal of Alzheimer's Disease : Jad
Roalf DR, Quarmley M, Mechanic-Hamilton D, et al. (2016) Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. 54: 325-35
Choi CH, Schoenfeld BP, Bell AJ, et al. (2016) Multiple Drug Treatments That Increase cAMP Signaling Restore Long-Term Memory and Aberrant Signaling in Fragile X Syndrome Models. Frontiers in Behavioral Neuroscience. 10: 136
Roalf DR, Moore TM, Wolk DA, et al. (2016) Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease. Journal of Neurology, Neurosurgery, and Psychiatry
See more...